LGM
Logos Global Management’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-150,000
| Closed | -$18.7M | – | 67 |
|
|
2024
Q3 | $18.7M | Hold |
150,000
| – | – | 2.02% | 21 |
|
|
2024
Q2 | $23.7M | Sell |
150,000
-250,000
| -63% | -$39.5M | 1.91% | 14 |
|
|
2024
Q1 | $51.8M | Buy |
+400,000
| New | +$51.8M | 4.19% | 5 |
|
|
2023
Q4 | – | Sell |
-200,000
| Closed | -$24.2M | – | 62 |
|
|
2023
Q3 | $24.2M | Sell |
200,000
-100,000
| -33% | -$12.1M | 3.23% | 9 |
|
|
2023
Q2 | $34.4M | Buy |
300,000
+80,000
| +36% | +$9.16M | 4.67% | 5 |
|
|
2023
Q1 | $30.3M | Hold |
220,000
| – | – | 4.34% | 7 |
|
|
2022
Q4 | $28.5M | Sell |
220,000
-130,000
| -37% | -$16.8M | 3.34% | 13 |
|
|
2022
Q3 | $38.7M | Sell |
350,000
-50,000
| -13% | -$5.53M | 4.76% | 7 |
|
|
2022
Q2 | $30M | Buy |
+400,000
| New | +$30M | 5.5% | 5 |
|
|
2020
Q4 | – | Sell |
-275,000
| Closed | -$38.6M | – | 64 |
|
|
2020
Q3 | $38.6M | Buy |
+275,000
| New | +$38.6M | 4.94% | 7 |
|
|
2020
Q2 | – | Sell |
-187,350
| Closed | -$18.3M | – | 61 |
|
|
2020
Q1 | $18.3M | Sell |
187,350
-38,652
| -17% | -$3.78M | 6.97% | 2 |
|
|
2019
Q4 | $29.2M | Buy |
+226,002
| New | +$29.2M | 7.19% | 2 |
|